tag gene-therapy-analytical-development 
PM360
APRIL 22, 2024
In the rapidly evolving landscape of healthcare, where breakthrough therapies and treatments emerge at an unprecedented pace, conventional boundaries are rapidly shifting. Post-launch, the role of Medical Affairs groups continues to evolve, focusing on driving patient outcomes and optimizing the use of therapies in real-world settings.
European Pharmaceutical Review
MAY 11, 2023
Novartis shared long-term data for its SMA gene therapy in March 2023, which indicated significant long-term motor-milestone achievements in spinal muscular atrophy (SMA). 3 The one-time gene therapy received final draft guidance from the National Institute for Health and Care Excellence (NICE) on 16 March 2023.
Expert insights. Personalized for you.
52 
Let's personalize your content